World's Best Scientists 2026 revealed!
Gian Luca Grazi

Gian Luca Grazi

D-Index & Metrics

Medicine

D-Index
82
Citations
35558
World Ranking
15883
National Ranking
622

Overview

Gian Luca Grazi is affiliated with the University of Bologna in Italy. Their research primarily focuses on Medicine, with a strong emphasis on Hepatology, Surgery, Epidemiology, Oncology, and Pulmonary and Respiratory Medicine. The scientist has published extensively across these areas, contributing to the understanding and treatment of liver and biliary diseases.

Major research topics covered by Gian Luca Grazi include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease and Transplantation
  • Gallbladder and Bile Duct Disorders
  • Liver physiology and pathology

Their recent scientific contributions include the following papers:

  • Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry, 2022, Journal of Hepatology
  • FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma, 2021, Journal of Hepatology
  • Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging, 2020, Digestive and Liver Disease
  • Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment, 2020, Digestive and Liver Disease
  • Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma, 2020, Cancers

Gian Luca Grazi frequently publishes in the following venues:

  • HPB
  • Updates in Surgery
  • Digestive and Liver Disease
  • Journal of Hepatology
  • European Journal of Surgical Oncology

The scientist has also collaborated extensively with other researchers in their field. Frequent co-authors include:

  • Felice Giuliante
  • Luca Aldrighetti
  • Guido Torzilli
  • Elio Jovine
  • Simone Famularo

Best Publications

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

    Laura Gramantieri;Manuela Ferracin;Francesca Fornari;Angelo Veronese

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

    Francesca Fornari;Laura Gramantieri;Manuela Ferracin;A Veronese

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

    Francesca Fornari;Laura Gramantieri;Catia Giovannini;Angelo Veronese

  • MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells

    Francesca Fornari;Maddalena Milazzo;Pasquale Chieco;Massimo Negrini

  • Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.

    Giorgio Ercolani;Gian Luca Grazi;Matteo Ravaioli;Massimo Del Gaudio

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria

    M. Ravaioli;G. L. Grazi;F. Piscaglia;F. Trevisani

  • MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality

    Laura Gramantieri;Francesca Fornari;Manuela Ferracin;Angelo Veronese

  • Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value

    Gian Luca Grazi;Giorgio Ercolani;Filippo Pierangeli;Massimo Del Gaudio

  • Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

    Franco Trevisani;Stefania De Notariis;Gianludovico Rapaccini;Fabio Farinati

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis

    Alessandro Cucchetti;Giorgio Ercolani;Marco Vivarelli;Matteo Cescon

  • Is portal hypertension a contraindication to hepatic resection

    Alessandro Cucchetti;Giorgio Ercolani;Marco Vivarelli;Matteo Cescon

Frequent Co-Authors

Antonio Daniele Pinna
Antonio Daniele Pinna University of Bologna
Domenico Alvaro
Domenico Alvaro Sapienza University of Rome
Mauro Bernardi
Mauro Bernardi University of Bologna
Luigi Bolondi
Luigi Bolondi University of Bologna
Fabio Piscaglia
Fabio Piscaglia University of Bologna
Eugenio Gaudio
Eugenio Gaudio Sapienza University of Rome
Luca Aldrighetti
Luca Aldrighetti Vita-Salute San Raffaele University
Franco Trevisani
Franco Trevisani University of Bologna
Miriam Capri
Miriam Capri University of Bologna
Andrew D. Cherniack
Andrew D. Cherniack Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the diverse careers connected to medicine? There are many flexible options to expand your qualifications or enter health fields from wherever you are. For example, a nutritionist online degree can open the door to preventive health, wellness coaching, and dietetics—fields increasingly vital to patient care.

Aspiring leaders may consider online mha programs cahme accredited for recognized training in healthcare administration. These programs help graduates understand the complexities of healthcare systems, preparing them for management roles in various settings.

Registered Nurses who want to advance their careers but have time constraints can choose rn bsn online programs no clinicals. These programs offer flexibility and allow nurses to earn a bachelor's degree without the need for additional clinical hours.

If you aim for the highest level of practice, consider the shortest msn to dnp program. This fast-track pathway provides advanced clinical and leadership expertise, equipping nurses to make a greater impact in patient outcomes and healthcare innovation.

Best Scientists Citing Gian Luca Grazi

Trending Scientists

Recently Published Articles